Back to all studies
CompletedNCT00280566

Ziprasidone Oral Capsule for Bipolar Mania; Bipolarity

This study is completed in the United States, in France, in Chile, .... It is testing ziprasidone Oral Capsule for Bipolar Mania; Bipolarity.

BipolarityDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Ziprasidone Oral Capsule may be useful for adults experiencing bipolarity.

What would participation involve?

Participants may receive Ziprasidone Oral Capsule, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Chile, in France, and in Germany.

Who is it mainly for?

This study appears to be mainly for adults with bipolarity.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateDecember 2005
Recruitment status
Completed
Enrollment listed in the registry
584
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Chile, ...
Age range
Over 18 Years
Official registry ID
NCT00280566
Official title
A Phase 3, Randomized, 6-Month, Double-Blind Trial in Subjects With Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer (vs Placebo Plus a Mood Stabilizer) Following a Minimum of 2 Months of Response to Open-Label Treatment With Both Agents

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00280566. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Chile · 2 sites
  • Pfizer Investigational Site
    Santiago, RM
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Santiago
    Site status: Not listed — confirm with the team
France · 4 sites
  • Pfizer Investigational Site
    Angoulême
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Brest Naval
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Douai
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Mulhouse
    Site status: Not listed — confirm with the team
Germany · 4 sites
  • Pfizer Investigational Site
    Berlin
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Berlin
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Cham
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Essen
    Site status: Not listed — confirm with the team
Guatemala · 1 site
  • Pfizer Investigational Site
    Guatemala City
    Site status: Not listed — confirm with the team
Hong Kong · 1 site
  • Pfizer Investigational Site
    New Territories
    Site status: Not listed — confirm with the team
India · 7 sites
  • Pfizer Investigational Site
    Ellisbridge, Ahmedabad
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Tirupati, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Bangalore, Karnataka
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Mysore, Karnataka
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Chennai, Tamil Nadu
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Ludhiana
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Pune
    Site status: Not listed — confirm with the team
Italy · 4 sites
  • Pfizer Investigational Site
    Catania
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Florence
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Parma
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Pisa
    Site status: Not listed — confirm with the team
Mexico · 2 sites
  • Pfizer Investigational Site
    Zapopan, Jalisco
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Mexico City, Mexico City
    Site status: Not listed — confirm with the team
Russia · 2 sites
  • Pfizer Investigational Site
    Arkhangelskaya Obl, Primorsky Raion
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Khot'kovo
    Site status: Not listed — confirm with the team
Spain · 3 sites
  • Pfizer Investigational Site
    Barcelona
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Barcelona
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Madrid
    Site status: Not listed — confirm with the team
Taiwan · 2 sites
  • Pfizer Investigational Site
    Taipei
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Taipei
    Site status: Not listed — confirm with the team
United States · 73 sites
  • Pfizer Investigational Site
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Scottsdale, Arizona
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    National City, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Sacramento, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    San Diego, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Temecula, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Temecula, California
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Altamonte Springs, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Fort Lauderdale, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Fort Myers, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Tavares, Florida
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Honolulu, Hawaii
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Des Plaines, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Libertyville, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Oak Brook, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Schaumburg, Illinois
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Terre Haute, Indiana
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Topeka, Kansas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Lexington, Kentucky
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Pittsfield, Massachusetts
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Taunton, Massachusetts
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Olive Branch, Mississippi
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Ridgeland, Mississippi
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Omaha, Nebraska
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Nashua, New Hampshire
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Paramus, New Jersey
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Teaneck, New Jersey
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Olean, New York
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Toledo, Ohio
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Bethany, Oklahoma
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Media, Pennsylvania
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Arlington, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Bellaire, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Houston, Texas
    Site status: Not listed — confirm with the team
Venezuela · 2 sites
  • Pfizer Investigational Site
    Caracas, Distrito Federal
    Site status: Not listed — confirm with the team
  • Pfizer Investigational Site
    Caracas, Distrito Federal
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, Ziprasidone Oral Capsule. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with bipolarity; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me